A. V. Panval, B. P. Chaudhari, A. B. Velhal, V. K. Redasani
A. V. Panval*, B. P. Chaudhari, A. B. Velhal, V. K. Redasani
YSPM’s Yashoda Technical Campus, Faculty of Pharmacy, Wadhe NH4, Satara, Maharashtra, India 415011.
Volume - 12,
Issue - 4,
Year - 2022
Transdermal Drug Delivery Systems comes under the category of Controlled drug delivery. The main goal of TDDS is to deliver the drug through skin into systemic circulation at controlled rate. TDDS is used to overcome the problems faced during drug administration through oral route. TDDS offers various advantages over different types of drug delivery like oral, IV etc. it provides control release of drug, avoids first pass metabolism, improves bioavailability, better patient compliance and many more. Drug with small molecules can be easily given by transdermal route. These Transdermal patches represents key outcome for growth in skin science and technology. This Review article explains all the detailed information of introduction of TDDS, its advantages and disadvantages, skin and drug permeation and its principle, contents of Transdermal patches it's types and evaluation test.
Cite this article:
A. V. Panval, B. P. Chaudhari, A. B. Velhal, V. K. Redasani. A Novel Tool for Controlled Delivery: Transdermal Drug Delivery System. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(4):304-8. doi: 10.52711/2231-5659.2022.00052
A. V. Panval, B. P. Chaudhari, A. B. Velhal, V. K. Redasani. A Novel Tool for Controlled Delivery: Transdermal Drug Delivery System. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(4):304-8. doi: 10.52711/2231-5659.2022.00052 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2022-12-4-8
1. Nidhi S. A Brief Review on Transdermal Patches. Organic and Medicinal Chem IJ. 2018; 7(2): 555707.
2. Chorghe B.R, Deshpande S.T, Shah R.D, Korabu S.S, Motarwar S.V. Transdermal Drug Delivery System: A Review. Research J. Pharma. Dosage Forms and Tech. 2013; 5(2): 65-69.
3. Sampath K.P, Bhowmik D, Chiranjib B, Chandira R.M. A review- Transdermal Drug Delivery System-A Novel Drug Delivery System and its market scope and opportunities. International Journal of Pharma and Bio Sciences.2010; 1(2).
4. Venkateswara R.T, Owku R.K. Review: Transdermal patch. Research J. Pharma. Dosage Forms and Tech. 2013; 5(1): 12-16.
5. Han T, Das D.B. Potential of Combined Ultrasound and Microneedles for Enhanced Transdermal Drug Permeation: A Review. Eur. J. Pharm. Biopharm. 2015; 89: 312–328.
6. Schoellhammer C.M, Blankschtein D, Langer R. Skin Permeabilization for Transdermal Drug Delivery: Recent Advances and Future Prospects. Expert Opin. Drug Deliv. 2014; 11: 393–407.
7. Patel R.P, Baria A.H. Formulation and evaluation consideration of transdermal drug delivery system. Int J Pharm Res 2011; 3: 1-9.
8. Solanki S.S, Patel K.B, Patel J.G, Patel M.P, Patel J.K. Transdermal Drug Delivery Systems: A Review. Research J. Pharm. and Tech. 5(6): June 2012; Page 757-763.
9. Arunachalam A, Karthikeyan M, Kumar D.V, Prathap M, Sethuram S, Kumar A.S. Transdermal drug delivery system: A review. Curr Pharma Res 2010; 1: 70-81.
10. Rastogi V, Yadav P. Transdermal drug delivery system: An overview. Asian J Pharm 2012; 6:161-70.
11. Vaseehabanu T.S, Sandhya K.V, Jayaveera K.N. Approaches and Current Trends of Transdermal Drug Delivery System- A Review. Research J. Pharma. Dosage Forms and Tech. 2013; 5(4): 177-190
12. Aggarwal G, Dhawan S. Development, fabrication and evaluation of transdermal drug delivery system-A review. Pharmainfo.net. 2009; 7(5): 1-28.
13. Soni M, Sharma D, Kaur T, Kumar S, Gupta G. Modeling Techniques- Novel Approach to Skin Permeability Measurement. Research J. Pharma. Dosage Forms and Tech. 2009; 1(1):13-17.
14. Ahlam Z.A, Maelíosa T.C, Ryan F.D. Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum. Pharmaceutics 2015; 7: 438-470.
15. Palanisamy P, Jaykar B, Venkateswarlu B.S, Chandira R.M, and Suriyan. D. A Review on Transdermal Drug Delivery System. Indian Journal of Natural Sciences.2020 August; 10(61):27035-27056.
16. Patel D, Chaudhary S.A, Parmar B, Bhura N. Transdermal drug delivery system: a review. The pharma innovation. 2012 Jun 1; 1(4): 66-75.
17. Hiroji M, Nagesh C, Devdatt J, Chandrashekhara S. Development and Evaluation of Transdermal Drug Delivery System using Natural Polysaccharides. Research J. Pharma. Dosage Forms and Tech. 2012; 4(5): 278-284.
18. Kim S, Kim J, Jeon O, Kwon I, Park K. Engineered polymers for advanced drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2009 Mar 1; 71(3): 420-30.
19. Arti, Kumara N, Gupta N.B. Transdermal patch with natural polymer for sustained release: A review. International Journal of Technology. 2021; 11(2):83-9.
20. Chaithanya N, Amaravathi V, Venkatesh P, Kalarini D.H, Prema R. A Review Article of Transdermal Drug Delivery System (TDDS). International Journal of Research in Engineering, Science and Management.2009; 2(11): 111-116.
21. Dua K, Sharma V.K, Sara U.V, Agrawal D.K, Ramana M.V. Penetration enhancers for TDDS: a tale of the under skin travelers. Advances in Natural and Applied Sciences. 2009 Jan 1; 3(1): 95-102.
22. Patel H.J, Trivedi D.G, Bhandari A.K, Shah A.D. Penetration enhancers for Transdermal Drug Delivery System: A Review. IJPI’s Journal of Pharmaceutics and Cosmetology 2011; 1(2).
23. Ezhumalai K, Ilavarasan P, Mugundhan M.R, Sathiyaraj U, Rajalakshmi A.N. Transdermal Patches in Novel Drug Delivery System. International Journal of Pharmacy and Technology. 2011; 3(2): 2402- 2419.
24. Li Y. A Quantitative Study of Drug Recrystallization in Drug-In-Adhesive Transdermal Patches Using Vibrational Spectroscopy. https://dsc.duq.edu/etd/1807
25. Kandavilli S, Nair V, Panchagnula R. Polymers in transdermal drug delivery systems. Pharmaceutical technology. 2002 May; 26(5): 62-81.
26. Hussain I, Ravikumar, Narayanaswamy V.B, Haque I, Hoque M. Design and Evaluation of Transdermal Patches Containing Risperidone. Asian J. Res. Pharm. Sci. 2016; 6(4): 208-222
27. Shaila L, Pandey S and Udupa N. Design and evaluation of matrix type membrane controlled Transdermal drug delivery system of nicotin suitable for use in smoking cessation. Indian Journ. Pharm. Sci. 2006; 68: 179-184.
28. Madhu L, Ravikiran N.T, KumarS.J. Formulation, Optimization and Evaluation of Glibenclamide Transdermal Patches by using chitosan Polymer. Asian J. Pharm. Tech. 2019; 9(1):01-07.
29. Aarti N, Louk A.R, RussselO.P and Richard H.G. Mechanism of oleic acid induced skin permeation enhancement in vivo in humans. Jour. control. Release 1995; 37: 299-306.
30. Jadhav S.B, Koshti A.R, Bari M.M, BarhateS. D. Formulation optimization and Evaluation of Transdermal patch of losartan potassium containing DMSO as permeation enhancer. Asian J. Pharm. Tech. 2019; 9(3):220-227
31. Vyas S.P and Khar R.K. Targetted and controlled Drug Delivery Novel carrier system1st Ed., CBS Publishers and distributors, New Delhi, 2002; 411- 447.
32. Liji J, Manju S, Jilby S. Formulation and Evaluation of Transdermal Patches of Selegiline. Asian Journal of Pharmacy and Technology. 2022; 12(2):96-0.
33. Bathe R, Kapoor R. Transdermal drug delivery system: formulation, development and evaluation-An overview. drug delivery. 2015; 6: 7.